InnoCare Pharma Limited (HKG:9969)
Hong Kong · Delayed Price · Currency is HKD 14.10
+0.52 (3.83%)
Dec 12, 2025, 3:59 PM HKT
InnoCare Pharma Market Cap
InnoCare Pharma has a market cap or net worth of 27.75 billion as of December 12, 2025. Its market cap has increased by 106.63% in one year.
Market Cap
27.75B
Enterprise Value
21.91B
Revenue
1.56B
Ranking
n/a
PE Ratio
n/a
Stock Price
14.10
Market Cap Chart
Since March 23, 2020, InnoCare Pharma's market cap has increased from 12.28B to 27.75B, an increase of 126.01%. That is a compound annual growth rate of 15.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 11, 2025 | 26.44B | 116.34% |
| Dec 31, 2024 | 12.22B | -6.80% |
| Dec 29, 2023 | 13.11B | -44.09% |
| Dec 30, 2022 | 23.45B | 11.18% |
| Dec 31, 2021 | 21.09B | 21.38% |
| Dec 31, 2020 | 17.38B | 41.53% |
| Mar 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 274.43B |
| Hansoh Pharmaceutical Group Company | 257.41B |
| JD Health International | 188.25B |
| Innovent Biologics | 143.10B |
| WuXi Biologics | 138.62B |
| Sino Biopharmaceutical | 121.03B |
| Akeso | 107.59B |
| Sichuan Kelun-Biotech Biopharmaceutical | 96.12B |